Legal & General Group Plc - XERIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$23,000
-83.3%
5,109
-81.7%
0.00%
Q4 2020$138,000
+331.2%
27,908
+416.1%
0.00%
Q3 2020$32,000
+88.2%
5,408
-16.3%
0.00%
Q2 2020$17,000
+30.8%
6,458
+5.3%
0.00%
Q1 2020$13,000
-65.8%
6,134
+13.1%
0.00%
Q4 2019$38,000
-13.6%
5,425
+21.6%
0.00%
Q3 2019$44,000
-8.3%
4,4610.0%0.00%
Q2 2019$48,000
+37.1%
4,461
+27.9%
0.00%
Q1 2019$35,000
+105.9%
3,487
+247.0%
0.00%
Q4 2018$17,000
-5.6%
1,0050.0%0.00%
Q3 2018$18,0001,0050.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders